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Cholesterol content of serum lipoprotein fractions in children and
adolescents maintained on chronic hemodialysis. fL. André, P. Gam-
bert, R. Bourquard, C. Lallemant, M. Vidailhet, A. Athias, P. Padieu,
and M. Pierson. Unite de Néphrologie Pédiatrique, Service de Pédia-
trie B, Chu de Nancy, et Laboratoire de Biochimie Médicale, Faculté
de Médecine, Ddon, France. A new method of cholesterol gas-liquid
chroniatographic assay in serum lipoproteins, separated by polyacryl-
amide gel electrophoresis needing only 2.5 p.1 of serum, was used to
analyze cholesterol content of serum lipoprotein fractions in children
and adolescents maintained on chronic hemodialysis. Lipoprotein anal-
ysis was performed on serum samples from nine hemodialyzed chil-
dren, 6 to 17 years old, and from nine pair-matched control children.
The mean serum triglyceride was significantly elevated in the hemodia-
lyzed group as were the mean total cholesterol and VLDL cholesterol
levels. The increase of LDL cholesterol concentration and the decrease
of HDL cholesterol concentration were not significant. Relative distri-
bution of cholesterol in the individual lipoprotein classes was different
in the two groups (P < 0.001): VLDL cholesterol = 6.3 0.8% of the
total cholesterol in the control group and 18.9 2.1% in the hemodia-
lyzed group; HDL cholesterol = 28.7 2% of the total cholesterol in
the control group and only 18.9 1.4% in the hemodialyzed group.
LDL cholesterol relative contents were not significantly different, but
the LDL to HDL cholesterol ratio increased from 2.41 0.29 to 3.41
0.23 (P < 0.05). HDL migrated faster than usual in the polyacrylamide
gel, and this fraction might have undergone some qualitative changes
which could be compatible with altered apoprotein HDL composition.
These results outline the potential risk of premature atherosclerosis in
unremic children on maintenance hemodialysis.
Effects of L-carnitine in hemodialyzed pediatric patients. J. L. Bacri, B.
Lacour, M. f. Tete, and M. Broyer. Hopital des Enfants Malades,
Paris, France. L-Carnitine effect was studied after a 4-week placebo
period in six hemodialyzed patients, 5 to 14 years old, with hypertrigly-
ceridemia. All received I g/day p. o. (33 to 83 mg/kg/day) for 8 weeks.
Results were as follows:
Before After F'
HDL cholesterol, mm 0.83 0,05 (.02 0.09 <0.02
HDL cholesterotilotal cholesterol, soot 0.16 0,016 0.2 0.025 <0.02
LDL cholesterol, ,,ssa 2.52 0,11 2.01 ((.19 <0.05
Triglycerides, ma, 2.605 0.52 1.99 0.38 <0.02
HDL triglycerides, ess, 0.28 0.06 0.395 0.036 NS
HDL Phospholip., ,ssa. 1.15 0.06 (.38 0.06 <0.05
Apo A, Ug/dI 190 0.0 231 4 <0.05
Total muscle L curnitine. s,,s,Iea/mp' 20.92 4 per/mg 36.9 1 6.6 per/mg prot.
Ingesta estimation obtained by dietetic inquiry in 4 patients showed no
change in 3 and an increase in 1, thereby validating the results. No
improvement of the myocardial performance was observed by M-mode
echocardiography after L-carnitine administration.
Effects of antidiuretic and sex hormones on papillary plasma flow in the
rat kidney. F. Bayle, L. Eloy, M. Trinh, J. Grunfeld, and L. Bankir.
INSERM U-90, Hôpital Necker, Paris, France. Papillary plasma flow
(PPF) was measured by the albumin accumulation technique. The
amount of '251-labeled albumin found in the renal papilla after a 15-sec
iv. infusion is proportional to PPF. Homozygous Brattleboro rats with
hereditary diabetes insipidus (DI) completely lack antidiuretic hormone
(ADH). In these rats we found significantly higher PPF than in control
heterozygous rats (HZ) (see Table). Acute (30 mm) arginine vasopressin
(AVP) (TI) or dDAVP (T2) infusion decreased PPF in DI rats (dDAVP
is a nonpressor analog of AVP with prolonged antidiuretic activity).
Chronic (5 days) dDAVP administration (i.p. Alzet minipumps) (T3)
further decreased PPF to control values. A significant correlation was
observed between PPF and urine osmolality (Uosm). The above experi-
ments were carried out on male rats. In subsequent experiments,
performed in Wistar rats, we observed a significant difference in PPF
between males and females, accompanied by a difference in Uoom.
Females (F) had higher PPF and lower Uosm than males (M). Forty-
eight-hour water deprivation (WD) increased Uosm to similar levels in
M and F. PPF in females, although significantly decreased, did not
decrease to the values observed in normal or WD males. These results
show that antidiuretic hormone and/or its effects on papillary osmolality
influence the plasma flow rate of the renal papilla. Sex hormones also
influence PPF since values observed in Wistar females remained higher
than those observed in males even when rats of both sexes reached
similar urine osmolality after water deprivation.
PPF UosmN p.1/mm g m0sm/kg H20
HZ 10 263 28 1877 70
DI 8 446 310 248 23
DI + TI 9 332 400 640 590
DI + T2 6 375 29 702 68°
DI + T3 6 262 40° 1745 73°
M 8 240 23 1925 (N = 2)
F 8 503 19b 1529 116
M WD 6 255 28 2406 107°
FWD 6 349± 11ab 2516± 108°
ap < 0.05 or less, DI vs. HZ or treated DI vs. nontreated DI or WD
vs. non-WD of same sex; bF vs. M or F WD vs. M WD.
Dimeric structure of IgA in mesangial deposits in Berger's disease. M.
C. Bene, G. Faure, and J. Duheille. Faculté de Médecine de Nancy,
Vandoeuvre, France. Dimeric IgA elaborated in mucosae present two
specific characteristics: they possess a J chain (for joining piece) and
are able to bind the secretory component (SC) secreted by the epitheli-
urn. Twenty cases of Berger's disease were found with these two
properties of mesangial deposited IgA. This study was performed by
immunofluorescence on frozen-cut kidney sections. Two methods were
used: (1) J chain was visualized by indirect immunofluorescence with an
antiserum of controlled specificity; (2) SC was prepared from human
colostrum with isolation, purification, and control done by immunodif-
fusion. This free SC was incubated in vitro with the kidney sections for
1 hour in a moist chamber. Its specific binding by mesangial IgA was
ascertained by direct immunofluorescence using an anti-SC antiserum
adsorbed with monomeric aggregated IgA, the specificity of which had
been controlled. A double labeling IgA/SC with antisera (anti heavy
chain and SC) rhodamin- and fluorescein-conjugated, respectively,
confirmed the localization of these two components. These tests were
positive for the 20 cases studied. It appears therefore, that the charac-
teristic mesangial deposits in Berger's disease are composed of dimeric
IgA of mucosal and not systemic origin.
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Factor XII deposition in extramembranous glomerulonephritis. J.
Berger, H. Yaneva, and F. Josso. Hôpital Necker, Paris, France.
Hageman factor has been demonstrated by immunofluorescence in 12
out of 23 cases of extramembranous glomerulonephritis (membranous
nephropathy). Factor XII was deposited, together with LgG, on the
outer aspect of the glomerular basement membrane. Prekallikrein was
associated with factor XII in every case. No factor XLI was found in 200
renal biopsies from patients with other renal diseases, including the
various other forms of glomerulonephritis. Specificity of antifactor XII
serum was controlled by inhibition of functional factor XII activity of
normal plasma and by double immunodiffusion against normal plasma
and factor-X1I-deficient plasma. The demonstration of factor XII in
membranous nephropathy is rather unexpected since neither antigen-
antibody complexes nor aggregated immunoglobulins seem to fix this
factor. It is possible to imagine that renal vein thrombosis associated
with membranous nephropathy might be related to factor XII activation
and that kinins generated by kallikrein might be involved in changes in
glomerular permselectivity.
Parathyroid carcinoma, adenoma, hyperplasia associated in a patient
with chronic renal insufficiency on dialysis. Y. Ber/and, M. Olmer, U.
Lebreuil, I. Grisoli. Service de néphrologie, Hôpita/ de Ia Conception,
Marseille, Service d'anatomopathologie, Hôpital Nord, Service de
chirurgie générale et endocrinienne, Hôpital de Ia Timone, Marseille,
France. A 62-year-old female patient with renal polycystic disease and
chronic renal insufficiency, requiring dialysis during the past 3 years,
presented with diffuse bone pain, predominantly lumbar and lassitude.
Radiologic studies showed diffuse osteoporosis and destruction of the
4th lumbar vertebra. Calcium levels were normal (2.30 to 2.50 mmoles)
with increased PTH levels (1820 l-EqIml). The presence of a cervical
mass led to the diagnosis of hyperparathyroidism. A cervicotomy was
performed with ablation of four parathyroid glands and autotransplanta-
tion of a portion of the left inferior gland on the arm. Pathology studies
showed the existence of carcinomas in the right superior and inferior
glands, adenoma of the left superior gland, and hyperplasia of the left
inferior gland. The association hyperplasia-adenoma-carcinoma could
be explained by an initial hyperplasia of the four glands due to renal
insufficiency, transformation of three in adenomas, two of which
became carcinomas. The patient's status was significantly improved
following surgery.
Effects of uremic middle molecules on auricular fragments of embryon-
ic heart. P. Bernard, J. Rinaudo, M. Crest, J. Moret, A. Crevat, P.
Galice, N. Fournier, A. Murisasco, S. Saingra, and R. Frayssinet.
Laboratoire de Biophysique Cellulaire, Faculté de Médecine Nord,
Marseille, France. We present the results obtained on auricular frag-
ments of embryonic chick hearts with plasma ultrafiltrates directly
obtained from uremic patients treated by hemodialysis, uremic middle
molecules separated from plasma ultraffitrates of the same patients
(peaks 7, 7c, and 7 d—e), and middle molecules separated from urine of a
normal subject (peak 7). Various effects were obtained according to the
concentration of the middle molecule fraction used: tachycardia, brady-
cardia, cardia arrest. All these effects were reversible by washing in
normal medium. Sodium chloride solutions of the same osmolarity were
without effect, so a simple osmotic effect was eliminated. Moreover,
peak 7 d—e was inactive. So we eliminated an artefact due to the
reagents and separation techniques.
Lipoprotein disorders in chronic ambulatory peritoneal dialysis. P.
Bones, A. Slingeneyer, M. L. Solera, M. Ringenbach, J. S. De Graeve,
H. Ton That, P. Valdiguie, C. Mion, J. M. Suc. Service de Nephrologie
et de Biochimie, Groupe INSERM U 133, Toulouse, et Service de
Nephrologie, Montpellier, France. This study was carried out on two
groups: group I, normal healthy volunteers (N = 10; age, 75.1 7.4)
without any cardiovascular disease or chronic renal failure; group 2,
patients with end-stage renal failure undergoing chronic ambulatory
peritoneal dialysis (CAPD) )N = 13; age, 68.5 5.6). These patients
were given a 1700-cal, 2-g/kg protein diet. We studied serum lipids,
glucose, and insulin levels in comparison with the control group. Our
results are as follows: fasting glucose was within the normal range,
plasma insulin, level was significantly higher (P < 0.01), total cholester-
ol was increased (P < 0.05), VLDL cholesterol was increased (P <
0.01), and HDL cholesterol was decreased (P < 0.05) with an increased
ratio (VLDL cholesterol + LDL cholesterol)/HDL cholesterol (P <
0.01), increased total triglycerides (P < 0.05), VLDL triglycerides (p <
0.05) and HDL cholesterol/HDL triglycerides ratio (P < 0.05). The
lipoprotein abnormalities are similar to type IV hyperlipemia and might
be induced by changes in carbohydrate metabolism. The increased
(LDL cholesterol + VLDL cholesterol)/HDL cholesterol ratio might
play a role as an atherosclerosis rask factor in these patients undergoing
CAPD. When compared with lipid abnormalities in a group of patients
on hemodialysis (N = 17; age, 54.4 14), the abnormalities in uremic
patients on CAPD appear to be higher, namely increased VLDL
cholesterol and VLDL triglyceride and an increased total CH/HDL CH
ratio.
Low level of antithrombin III and plasma antithrombin activity in
nephrotic syndrome. F. Bouissou, B. Boneu, M. Abbal, P. Sie, C.
Caranobe, and P. Barthe. C.H.U. Purpan, Toulouse, France. It has
been suggested that thrombosis, a major complication in the nephrotic
syndrome (NS), was related to low concentration of antithrombin III
(ATIII). We studied 28 children with idiopathic NS and determined the
plasma antithrombin activity according to the technique of Howie, the
ATIII by electro immunodiffusion, the a2 macroglobulin (a2M) and al
antitrypsin (aAT) by radial immunodiffusion. We compared the results
with normal children and adults. In NS, the decrease of ATIII and
aIAT, by urinary loss, is correlated with hypoalbuminemia; however,
when compared to controls, plasma antithrombin activity is higher
because of the increase of the a2M (negative correlation with ATIII and
serum albumin). In spite of the dramatic reduction of ATIII in 15
children, no thromboembolic complication occurred. These results
suggest that in NS the determination of ATIII alone has no value to
predict thrombotic risk, whose pathophysiology seems more complex.
Heparin in these patients is not effective and could be dangerous
because of inhibition of ct2M antithrombin activity.
High frequency of HLA-DR-7 in children with idiopathic nephrotic
syndrome: Correlation with allergic status. F. Bouissou, A. De Mouzon,
P. Barthe, and E. Ohayon. CHU Purpan, Toulouse, France. Idiopathic
nephrotic syndrome (INS) is likely to be underlied by immunologic
mechanisms with special incidence of atopic symptoms. In these
patients with atopy, an increased frequency of HLA-BI2 was found.
Because there is no data on HLA-DR typing on this subject, it is the aim
of this work. Fifty-four children with INS (mean age, 8.1 3.5 yr) were
studied. HLA-A and =B typing was performed by the NIH standard
microlymphocytotoxicity technique, and HLA-DR by double fluores-
cence. The results were compared to 49 children with various glomeru-
lonephritis (mean age, 11.1 3.6yr) and 91 healthy blood donors of the
same area. Allergic status was defined by clinical, biological (IgE), and
skin tests criteria. No significant deviation was found for HLA-A and
=B antigens in the three groups studied and between patients with and
without allergic status. High DR-7 frequency was found in INS (67% vs.
31%; relative risk, 4.4; P = 2.4 10-i). No obvious correlation could be
demonstrated between HLA-DR-7 and steroid responsiveness, clinical
outcome, and histologic studies. When these patients are divided
according to allergic status, HLA-DR-7 frequency was 92% (22/24) in
patients with allergy vs. 44% (11/25) in nonallergic INS (relative risk,
14; P = 0.00037). These results suggest that INS could be an immuno-
logic disorder who pathogenesis is related to the major histocompatibil-
ity complex-linked immune response gene near DR-7.
Factors of risk of aseptic bone necrosis in renal transplant patients. G.
Bouteiller, F. Dehais-Goffinet, D. Durand, H. Ton-That, and J. M.
Suc. Service de Nephrologie, CHU Rangueil, Toulouse, France.
Osteonecrosis (ON) in renal transplant recipients is still a disease in
which the factors of risk are unknown. The aim of the present study was
to determine which of clinical, biological, and radiological data could be
used as possible predictors of osteonecrosis. Some parameters ap-
peared as no value to characterize the group of ON patients: age, sex,
time on dialysis, phosphoremia, alkaline phosphatase, cholesterolemia,
cumulative dose of corticosteroids. However, a multifactorial analysis
performed with a computer on 49 patients (19 of them had ON) showed
that it was possible to evaluate the risk of ON through the following
formula: number of transplant rejections treated by corticosteroids +
mean overweight during the first 6 months after transplantation +
hyperparathyroidism assessed on radiologic criteria — mean calcemia in
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the first month following transplantation R. According to a score
obtained by positive or negative points for each parameter, the higher is
R, the greater the risk of ON. Thus, among 21 patients with R 0,
none has ON. In contrast, the 9 patients with ON are found among the
28 others with R 1. As no multifactorial analysis has been so far
published in this regard, our results need to be confirmed. Neverthe-
less, it suggests that ON might be a multifactorial disease, as the result
of the conjunction of various metabolic abnormalities.
Continuous ambulatory peritoneal dialysis: Two years' experience. B.
Canaud, A. Slingeneyer, and C. Mion. Dept. Nephrology, C.H.U.
Montpellier, France. Since Sept. 1978, 94 patients (51 males, 43
females) were treated by continuous ambulatory peritoneal dialysis
(CAPD) using the following technique: (1) dialysate in 2-liter plastic
bags with a luer connector; (2) a bacteriologic filter on the connecting
line; (3) dialysate containing 15, 25, or 40 g of dextrose and 130 or 140
mmoles/liter sodium. There were 3- to 5-bag exchanges per day. The
cumulative treatment duration was 59.6 patient years (mean/patient: 7.6
months). Residual creatinine clearance was 2.0 0.7 mI/mm. Thirty-
one patients started their maintenance therapy by CAPD; 45 had
previous intermittent PD (IPD) and 8 previous hemodialysis (HD). An
excellent blood pressure (BP) control was obtained in all patients.
Orthostatic hypotension, observed in 16 patients during the first month
on CAPD, improved in 9 patients with the use of 140 mmoles/liter
sodium dialysate, but persisted in 7 patients (BP < 90/60 mm Hg).
Refractory edema was observed in 18 patients. In 38 patients treated for
6 months or more by CAPD, biological results were (means SEM):
creatinine, 103 7 mg/liter; urea, 1.1 0.1 g/liter; total proteins, 64.8
2.6 g/liter; serum albumin, 32 2 g/liter; triglycerides, 3.9 0.7 g/liter;
hemoglobin (Hb), 11.7 0.5 g/dl. Thirty-seven peritonitis episodes
were observed; 4 were associated to an acute visceral disease; the
overall peritonitis incidence was I episode every 19.6 patient treatment
months. In September 1980, 48 patients were still on CAPD, 22 had
been transferred to IPD and 6 to HD; 18 patients had died. These results
confirm the value of CAPD as a long-term treatment of end-stage renal
disease, Besides its role in maintaining an equilibrium state, CAPD
obtains a good BP control without drug and an increase in Hb in most
cases. With the use of a bacteriologic filter, the peritonitis incidence is
maintained at an acceptable level. However, the high number of
transfers from CAPD to HD and/or IPD suggests that CAPD must be a
part of a program integrating all modes of end-stage renal disease
therapy.
Combination of a membranoproliferative glomerulonephritis with a
benign monoclonal gammopathy: Report of two cases. P. L. Caraman,
M. Kessler, F. Maurice, C. Huriet, G. Rauber and J. Duheille. Centre
Hospitalier Regional, Nancy, France. We report two cases of mem-
branoproliferative glomerulonephritis with a lobular tendency associat-
ed with a benign gammopathy gamma-2 lambda-2. The first patient, a
5 I-year-old woman, shows a nephrotic syndrome, positive circulating
immune complexes, a normal level of total complement and of compo-
nents C3 and C4. The second patient, a 50-year-old male, shows a
peripheral vascular disease associated with a type I cyroglobulinemia
similar in composition to the circulating monoclonal immunoglobulin;
he has a nephrotic syndrome with severe renal failure requiring
hemodialysis. The peripheral vascular disease is improved by the
plasma exchanges. Total complement and C3 levels are normal; there
are no circulating immune complexes. Immunofluorescent analysis of
the renal biopsy in the two patients discloses thin endomembranous
deposits of C3 and, above all, thick deposits of C9 at the level of
glomerular and tubular basement membranes. The benign nature of the
two gammopathies is based on the normal myelogram and the normal
level of plasma immuoglobulins with a followup of 2 years for the first
patient and 1 year for the second one.
A scanning electron microscope study of renal vasculature of the rat on
corrosion casts. D. Case/las, A. Mimran, M. DuPont, and B. foyer.
Med.D, CHR Saint-Charles, Montpellier, France. To gain additional
information on the existence of arterial shunts in renal vasculature, we
used microsphere injection into the artery of a perfused kidney prepara-
tion combined with corrosion-replication of arterial vasculature (Bat-
son's resin). Use of this technique afforded the advantages of both rapid
light microscopic detection of shunts and of high three-dimensional
resolution by the scanning electron microscope. Our results clearly
demonstrate the existence of arterial pathways bypassing glomeruli
throughout the renal cortex with increasing frequency from the superfi-
cial to the juxtamedullary cortex. However, quantitative analysis
indicated an absence of age-dependency in the latter area. In rats from
weaning to more than a year old, approximately 10% (range, 4 to 22%)
of juxtamedullary glomeruli were bypassed by aglomerular vessels or
glomerular shunts. From results of microsphere studies it may be
concluded that aglomerular circulation plays a negligible hemodynamic
role in the basal condition. However, its significance in abnormal
conditions cannot be ruled out.
T Lymphocyte functions in mercuric chloride-induced membranous
glomerulonephritis in man: Evidence for a defect of presentation of the
histocompatibility class II molecules at the cell surface. B. Charpentier,
N. Faux, G. Manigand, D. Fries. Service de Néphrologie et Service de
Médecine Interne, Hopital Paul Brousse, Villejuif, France. Membra-
nous glomerulonephritis (MON) is one of the well-documented manifes-
tations of autoimmunity during chronic mercuric chloride intoxication.
We have carried out immunologic investigation of the T cell functions in
a patient presenting mercuric-chloride-induced MGN. Circulating au-
toantibodies and immune complexes were absent from the serum.
Lymphocyte transformation with mercuric chloride over a wide range
of doses (10-s to I0 st) was negative. E rosettes, mitogen reactivity,
allogeneic reactivity evidenced by a one-way mixed lymphocyte culture
gave normal results. These findings contrasted with severe impairment
of lymphocyte stimulation capacity. This defect could be related to the
inability of D,DR products to be exposed at the cell surface, impeding
the allogeneic recognition by foreign lymphocytes. This lymphocyte
defect in the course of mercuric chloride MGN in man would be
correlated with lymphocyte abnormalities found in experimental mercu-
ric chloride-treated rats. In Brown Norway strain, mercuric chloride
intoxication leads to an autoimmune GN with abnormalities of B
lymphocyte functions. This present study favors a direct role of
mercuric chloride on lymphocytes rather than a direct action on the
glomerular basement membrane.
Treatment of 298 hypertensive patients by tienilic acid: A retrospective
study. M. Colliard, P. Tcherdakoff. Hópital Ambroise Pare, Boulogne,
France. Two hundred ninety-eight hypertensive patients received tieni-
lic acid (ticrynafen) as part of antihypertensive therapy. in 295 cases,
this drug was associated with a potassium-sparing diuretic, and the
average length of treatment was 24 months. Considering the whole
group of patients, the average serum creatinine did not change signifi-
cantly. A moderate rise in serum creatinine levels was noted in 17 cases
but cannot be specifically linked to the therapy in all certainty. Two
hundred fifty-three cases were investigated systematically for serum
transaminase levels during treatment: serum levels were moderately
elevated in 18 cases, but the relation between tienilic acid and this rise,
although possible, cannot be proven in these patients. According to the
present data, it seems that the danger of nephrotoxicity of associating
tienilic acid and potassium-sparing agents has been overestimated and
that such an association can be used. The danger of hepatotoxicity of
the drug is real but the occurrence is rare and should be put in balance
with the danger of other antihypertensive drugs and of other hypourice-
mic drugs such as allopurinol.
Blood kinetics and a-blocking effect of oxprenolol and its main conju-
gated metabolite after a single oral dose in hemodialyzed patientS. P.
Dayer, P. Glasson, A. Gorgia, L. Ba/ant, and J. Fabre. Department of
Medicine, University of Geneva, Switzerland. Oxprenolol (Ox) is a
rapidly metabolized f3-adrenoceptor blocking drug, widely used in
uremic patients. The aim of this study was to establish: (1) the kinetics
of Ox and its main metabolite, a glucuronide conjugate (Cm), in renal
failure, (2) the cardiac effect of Ox, Cm, or other metabolites retained in
uremia, (3) the relevance of Cm as a reserve pool of Ox, as postulated
for propranolol. The kinetics of Ox were studied on whole blood using a
gas-liquid chromatography; Cm blood levels were obtained as the
difference in Ox levels between 3-g1ucuronidase-hydro1yzed and non-
hydrolyzed samples. The 3-blocking effect was measured by means of
the reduction of exercise techycardia on a bicycle ergometer before, 3
hr, 5 hr, and 9 hr after an oral dose of 40mg of Ox. Work load was set to
reach a mean cardiac frequency of 135 beats/mm before medication. Six
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hemodialyzed patients free of other disease or drug were studied
fasting. The results show that kinetics of Ox are not affected by renal
failure: blood concentration 1 hr after the dose was 316 (SD) 160 ng/
ml; area under the blood concentration curves (AUC,t) was 670 277
ng mt' hr; t'/2 was I 0.4 hr. Cm, on the contrary disappeared
extremely slowly: t½ was 123 74 hr rage from 60 to 234 hr (a more
than tenfold increase with respect to normal subjects). In spite of the
retention of Cm and other unmeasured hydrophilic metabolites, the
duration of cardiac effect was short, comparable with the values
observed in normal subjects. During hemodialysis sessions Cm was
cleared with a tV2 of 5.6 hr. Conclusion. (1) The kinetics of Ox are not
altered by renal failure but Cm elimination is markedly reduced. (2)
There are no "clinically active" metabolites of Ox in man, as judged by
the lack of noticeable cardiac effect after a few hours. (3) Aftera single
40 mg dose of Ox in anuric patients, the Cm pool does not seem to play
a major role in the late effect of Ox. Therefore, Ox may be administered
to uremic patients without modification of the dosage regimen.
Leucopenia and disturbances in pulmonary gas exchange during hemo-
dialysis with different types of membranes. W. De Backer, G. Verpooten,
P. Vermeire, J. P. Van Waeleghem, H. Van Beek, L. Muyl/e, and M. E.
De Broe Depts. of Nephrology, Hypertension and Pulmonary Medi-
cine, University of Antwerp, Wilrijk, Belgium. A decrease in peripheral
leukocyte count and arterial oxygen tension (aPo2) is frequently ob-
served during the first hour of hemodialysis (HD). Intrapulmonary
leukostasis induced by activation of the complement system and
subsequent hypoxemia is the explanation given by a number of investi-
gators. Others propose alveolar hypoventilation caused by loss of
carbon dioxide through the hemodialyzer. We made a comparative
study in 6 patients using three different types of hemodialyzers:
cuprophane (CP), celluose-acetate (CA), and polyacrilonitryl (PAN). At
several time intervals, simultaneous measurements of total and differ-
ential white cell count, blood gases, histamine and complement factors
were performed. During 7 HD sessions using CP and 4 HD sessions
using PAN, ventilation studies were performed using mass spectrome-
try to obtain direct measurement of the alveolar oxygen tension (aPo2)
and the alveolar-arterial oxygen gradient (al-a-Do2). One hour after the
start of HD, hypoxemia was significantly more pronounced in HD using
CP compared to CA (P < 0.05) and PAN (P < 0.025). When the
clearance rate of histamine is taken into account, it seems likely that
significant amounts of histamine were produced in HD with all mem-
branes. Activation of the alternative pathway of the complement
system was qualitatively demonstrated in some HD using CF. The al-a-
Do2 was significantly increased during the first hour in HD Using CP (P
<0.02) where as in HD using PAN no significant increase was found (P
>0.05). In the same period, no significant decrease of aPo2 occurred (P
> 0.05). From these data, we conclude that there is a marked difference
in hypoxemia and leucopenia using different membranes. The increased
directly measured al-a-Do2 indicates that VIQ inequality is the most
likely cause of hypoxemia during the first hour of HD. The role of
histamine and complement activation in the genesis of uneven V/Q is
still speculative.
Acute nephrotoxicity of antibodies directed against a basement mem-
brane proteoglycan. J. B. Foidart, J. M. Foidart, J. Hassell, C.
Dechenne, and P. Mahieu. Department of Medicine, University of
Liege, Liege, Belgium, and Laboratory of Developmental Biology and
Anomalies, N.J.D.R., N.i.H., Bethesda, Maryland, USA. The glomer-
ular basement membrane (GBM) is composed of collagenous and
noncollagenous glycoproteins and of proteoglycans. A proteoglycan
containing heparan sulfate has been purified from the BM matrix
secreted by a murine tumor (EHS sarcoma). Antisera directed against
this proteoglycan were obtained by immunization of rabbits with the
purified antigen mixed with complete Freund's adjuvant. Their specific-
ity was demonstrated by indirect immunofluorescence performed on
normal rat kidney slices, and by cross-immunoabsorption. Their neph-
rotoxicity was studied by injecting iv. 0.5 to 2 ml of antiserum into
Sprague-Dawley rats weighing 200 to 250 g. The following were
observed: (1) 80% of the animals developed proteinuria (20 to 50 mg/dl)
1 hr after the injection; this proteinuria reached its maximum 1 hr later
and disappeared 2 hr later; (2) the proteinuna increased proportionally
to the volume of antiserum injected; (3) control rats receiving normal
rabbit serum did not develop significant proteinuria; (4) all the kidneys
from rats injected with the antisera exhibited linear deposits of rabbit
IgG along the GBM, whereas no rat C3 was detectable; (5) all the rat
kidneys presented a mild and transient leukocyte proliferation; (6) the
colloidal iron staining of glomeruli was strongly decreased 1 hr after the
injection of antibodies, but returned to normal 2 hr later; (7) from in
vitro perfusion studies, it appeared that the proteinuria was not
complement-dependent. These data demonstrate that antisera directed
against this BM proteoglycan are nephrotoxic. They also suggest that
this nephrotoxic activity may be related, in part, to a functional
alteration of some anionic sites of the GBM.
Fracturing bone disease in a hemodialysis patient probably related to
oral aluminum ingestion. G. Fournier, J. L. Gaillard, R. Pourdon, and
T. DrOeke. Service d'hemodialyse, Centre Hospitalier de Chartres,
Laboratoire de Biochimie-Toxicologie, Hópital Fernand Widal, and
Department de Nephrologie, Hôpital Necker, Paris, France. The case
of a hemodialysis patient is reported who suffered from spontaneous
bone fractures with X-ray and bone microscopy evidence of osteomala-
cia probably related to aluminum intoxication. Her elevated plasma
aluminum concentration (16.6 moles/Iiter) was not due to an increase
in dialysate aluminum concentration but occurred via the oral route
since the patient had intestinal hyperabsorption of aluminum. Evidence
of increased intestinal absorption of the metal was provided by an oral
aluminum overload (2 x 12 g of aluminum hydroxide administered
during 48 hrs). An identical overload performed in two control hemodi-
alysis patients with a much lower plasma aluminum concentration did
not induce such a hyperabsorption. The cause of the augmented
intestinal absorption of aluminum remains unknown. Conclusion: The
possibility of an increased intestinal absorption of aluminum should be
considered in each chronic hemodialysis patient with hyperaluminemia.
Effect of captopril on renin secretion by intact and denervated kidneys
in the dog. J. P. Girolami, J. L. Ader, D. Durand, T. Tran Van, andJ.
M. Suc. Laboratoire de Physiologie and INSERM U 133, CHU de
Ranqueil, 31062 Toulouse, France. Though RS is suppressed by
chronic renal denervation, the effect of acute denervation and the
responsiveness of renin secreting cells have not been studied. Thus, we
assessed these latter points by using a comparison between the renin
secretory responses of the denervated (DK) and of the controlateral
intact kidney (1K) of dogs (N = 12) to inhibit angiotensin II formation
produced by the converting enzyme inhibitor captopril (1 mg/kg, i.v.).
Renal hemodynamic and functional parameters were monitored 30 mm
after surgery for four consecutive periods. After unilateral denervation,
sodium excretion (UNOV), fractional sodium excretion (FENa), and
renal blood flow (RBF) were greater by 134, 86, and 22%, respectively,
while glomerular filtration rate (GFR) did not differ and RS rate was
lowered by 40% when compared to the 1K. Captopril produced a
significant decrease in blood pressure (—24 5 mm Hg) and similar
relative increases in UNaV, FENa, and RBF above their respective
controls in both kidneys while GFR remained constant. In contrast,
whereas RS rate in the 1K rose progressively after captopril (from 63
31 before captopril to 308 241 ng/min 60 mm after captopril), the RS
rate of the DK did not rise beyond an initial increase (from 37.5 21
before to 107 78 ng/min 20 mm after) and remained significantly
below those of the 1K at all time periods. Our results indicate that a
relative refractoriness of the renin secreting mechanism occurs soon
after denervation. It possibly reflects the net effect of an increase in the
transmural pressure at the baroreceptor site, an increase in sodium
delivery to the macula-densa and/or a reduction in direct neural input to
the renin secreting cells.
Renovascular hypertension in the elderly: Poor prognosis and progres-
sion of the vascular lesions. R. Gonthier, J. C. Sabatier, J. Toulon, B.
Laurent, C. Genin, C. Veyret, A. Gelet, J. Tostain, X. Barral, and F.
Berthoux. CHR Saint-Etienne, France. We analyzed, retrospectively,
12 patients, aged from 63 to 73 years, with renovascular hypertension
due to atheromatous lesions either unilateral or bilateral (4 out of 12).
Malignant or accelerated hypertension with multiple visceral involve-
ment was frequent (8 out of 12). The stenoses of the proximal parts of
the renal arteries were rapidly progressive, ending in complete throm-
bosis in 8 cases. Five patients received only a medical treatment, but in
2 GFR deteriorated and in two others blood pressure was poorly
controlled. Five patients underwent renal surgery nephrectomy (2),
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aortorenal bypass (2), and bypass plus nephrectomy (1); however 2
recovered normal GFR, but 2 died in the postoperative period. Three
patients had selective embolization of the renal artery, but only one was
definitively improved and one was later nephrectomized. These data
emphasize how difficult is the therapy of renovascular hypertension in
the elderly.
Increase of the specific cs-glucosidase acting upon the disaccharide units
of collagens and basement membranes in the kidney cortex of diabetic
rats. A. Grochuiski, G. Hirbec, J. Peyroux, and M. Stern berg. Départe-
ment de Biochimie, Faculté de Médecine Broussais, Paris, Laboratoire
de Pharmacodynamie, Faculté de Pharmacie, Paris, and Laboratoire
d'Anatomie Pathologique, CHU Henri-Mondor, Creteil, France. A
novel a-glucosidase has been described which appears to be highly
specific for the hydroxylysine-linked disaccharide units of basement
membranes and collagens. It was therefore of interest to find out how
its activity varied in the diabetic kidney since a thickening and an
increased degree of hydroxylysine glycosylation in the GBM and an
elevated specific glucosyltransferase activity in kidney cortex have
been reported. Wistar male rats of 210 g were injected iv. with 55mg/kg
of body of streptozotocin (Sigma) and sacrificed 19 weeks after the
injection. Mean blood glucose level was 58 3 vs. 7.8 0.1 mmoles/
liter in normal nonfasting controls. Kidney cortex glucosyl-galactosyl-
hydroxylysine glucohydrolase specific activity was significantly in-
creased in the dialyzed diabetic kidney cortex homogenate (21.1 1,3
vs. 11.4 1.2 nmoles/hr/mg protein; P < 0.001). This increase in the
specific ct-glucosidase contrasted with a decrease in the nonspecific a-
glucosidase activity with para-nitrophenyl-a--glucoside as substrate
(76.4 4.2 vs. 133 10 nmoles/hr/mg; P < 0.001). The nonspecific 3-
galactosidase activity on paranitrophenyl-j3-D-galactoside was also
found to be significantly decreased in the diabetic kidney cortex
homogenate (721 36 vs. 1100 80 nmoles/hr/mg; P < 0.01) as
previously described by Fushimi and Tarui in the x 10,000g supernatant
of kidney cortex homogenate. Specific 13-galactosidase activity on
galactosyl-hydroxylysine residues was found to be very low in normal
kidney cortex and not significantly modified in the diabetic. The
selective increase of the a-glucosidase specific for the disaccharide
units was confirmed in the kidney cortex homogenate after 23 and 28
weeks of diabetes and disappeared after a 3-week treatment by insulin.
It was associated with a thickening of the GBM with nonhomogeneous
densification of the lamina densa. It might reflect an increased glucose
turnover in the kidney basement membranes consistent with the
increased specific glucosyl-transferase activity reported by Spiro and
Spiro.
Epidemiologic survey of analgesic nephropathy in France. J. Guenel.
Hôpif a! Saint-Jacques, Names. As in several other countries, epidemi-
ologic data are not yet available in France concerning the frequency of
analgesic nephropathy (AN). It is thought to be rare, however. Since
October 1979, we have undertaken a nationwide retrospective survey
covering 6 years. Thirty-nine Departments of Nephrology were consult-
ed and 28 answered. A total of 206 cases of AN were recorded for an
average of 34.3 cases per year. This number represents about 2% of the
patients with end-stage renal failure. During the same period, 30
patients with AN started regular dialysis treatment in 13 centers, i.e.,
about 2% of all new patients in dialysis. This rate is close to that given in
the annual statistical report of EDTA for Europe (2.5 a 3.5%) but lower
than that of some countries: 10% in the USA, 17.5% in Switzerland,
18% in Belgium, 20% in Australia. In France, distribution is unequal
between areas. AN is more frequent in the north (3.36% of the cases of
chronic renal failure) than in the south (0.25%). This difference may be
explained by local habits of using freely available drugs as well as by the
difficulty of diagnosis owing to inaccurately defined criteria.
Blood flow of subcutaneous arteriovenous shunts in chronic hemodialy-
sis patients: Atraumatic measurement by dye-dilution method. T. Haas,
G. Dongradi, P. Rocha, J. C. Kahn, B. Baron, J. P. Fendler. Poissy
Hospital, France. Blood flows in 9 side-to-end arteriovenous fistulae
and 7 arteriovenous grafts were measured in 16 chronic hemodialysis
patients. Dye injections were given into the efferent vessel of the shunt
close to the arterial anastomosis. Dye dilution was measured into the
efferent vessel more than 5 cm distal to the injection site. Dye was
injected instantaneously by a small needle (amounts between 1.25 and
2.5 mg injected in a volume of 0.5 to 1.0 ml). In the case of arteriove-
nous fistulae, a thermographic study confirmed prior to the study the
absence of any collateral vein between the injection site and the sample
site. Blood was collected at a continuous flow rate of 23 mI/mm from the
"arterial" line of a double-lumen hemodialysis needle and was rein-
fused distal to the blood sample point through the "venous" line of the
double-lumen needle. Such a needle permitted: (1) a continuous reinjec-
tion of the blood to the patient, and (2) a dialysis session after
measurement without a new blood access. Blood flows measured were
between 0.39 and 2.6 liters/mm (mean = 1.35 liters/mm). Morphology
and reproducibility of dilution curves were good in 15 cases. These
results suggested a homogeneous mixing of blood and tracer, and an
insignificant error related to the pulsatility of the flow and the short
duration of the dilution curves. An atraumatic dye-dilution method
permits, except in all but rare cases, precise measurement of blood flow
in s.c. arteriovenous shunts of chronic hemodialysis patients. Blood
access is similar to the blood access for dialysis. A sample of 25 ml of
blood for calibration of the dilution curves is the only disadvantage of
this method.
Bartter's syndrome and extrarenal hyperprostaglandinism In a patient
with brain tumor. B. Hurault de Ligny, A. Baumelou, A. Hornych, D.
Pierre and M. Legrain. The occurrence of seizures and episodes of
aphasia in a 39-year-old woman led to the discovery of a brain tumor. A
year later, hypokalemia was evidenced. Brain CAT scan showed a left
parietal hypodense, clearly demarcated area. Histologic examination of
the surgical biopsy from left prerolandic region showed glial prolife
ration compatible with the diagnosis of a grade I astrocytoma. The
persistent hypokalemia in the range of 2 to 2.6 mmoles/liter was
symptomless. There was a marked kaliuresis (88 mmoles/24 hr). Plasma
magnesium was low (0.62 mmoles/liter). Search for diuretics in the
blood and in the urine and for phenolphtalein in the stools were
negative. Supine plasma renin activity was increased (14 ng/ml/hr;
normal value, 2 to 3 ng/ml/hr) and was stimulated in the upright position
(35 ng/ml/hr). The same pattern was found for plasma aldosterone
(supine 30 pg/mI; normal value, 0 to 25 pg/mI; upright, 190 pg/mI).
Urinary prostaglandin excretion was also considerably increased: pros-
taglandin E2 (PGE2), 1017 ng/24 hr (normal value, 183 22 ng/24 hr);
PGF2, 1268 ng/24 hr (normal value, 441 80 ng/24 hr). These biologic
abnormalities were corrected by indomethacin (3 mg/kg/day orally for 6
days). The diagnosis of Bartter's syndrome was based on these clinical
and biological data. On account of the presence of the brain tumor, the
site of prostaglandin overproduction was sought by evaluation of
prostaglandin levels in multiple venous blood samples collected during
selective catheterization. Increased plasma PGE2, PGF2 , 6 -keto-
PGF1 and TxB2 concentrations were found in all blool samples.
Particularly high levels were observed in the left jugular vein and
superior vena cava whereas increases were very slight in both renal
veins. These results demonstrated the essentially extrarenal and possi-
bly tumoral origin of the hyperprostaglandinism. They also point out the
possible association of Bartter' s syndrome and brain tumor.
Results of the controlled trail of Institut Pasteur hepatitis B vaccine in
48 French hemodialysis units. P. Jungers, P. Guesry, A. M. Courouce,
A. Laplanche, E. Benha,nou, B. Lacour, F. Degos, and J. Crosnier.
Hôpita! Necker, Paris, France. Institut Pasteur Production vaccine was
prepared from plasma of chronic carriers of HB5Ag (ad and ay
subtypes), negative for HBeAg, inactivated by 1/10,000 formaldehyde,
with aluminum hydroxide as adjuvant. Each I-mI dose contained 5 ig
of HBsAg. The vaccine lot was tested on chimpanzees for safety and
immunogenicity. After informed consent and exclusion of subjects
positive for HBsAg, anti-HBc, or anti-HBs, 367 high-risk permanent
staff members of 48 French hemodialysis centers were enrolled in the
trial. These volunteers received randomly, double-blind, three s.c.
injections of 1 ml of either vaccine or placebo, at monthly intervals and
were followed monthly during a one-year period. The incidence of side-
effects did not significantly differ between vaccine (17%) and placebo
(15%) groups. HBV infections were observed in 12.3% of placebo
recipients distributed throughout the whole 12-month followup period,
and in only 3.6% of the vaccine recipients (P < 0.005), none occurring
after the 63rd day following the first injection. An immune response,
defined by anti-HBs titers 10 mIU/ml on at least 5 successive
samples, was obtained in 94% of vaccine recipients. Anti-HBs level was
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2,433 1,077 mIU/ml (mean 2 SEM) 4 months after the 1st injection,
and 904 231 mUl/mi 8 months later. Following the booster injection
(given between the 14th and the 18th month), it reached 74,740 33,490
mIU/ml, These results demonstrate the safety, immunogenicity, and
efficacy of the Institut Pasteur hepatitis B vaccine.
Hematuria, red cell casts, and renal biopsy. A. Kahan, E. Ronco, L.
Morel-Maroger, F. Mignon, M. Beaufils, A. Meyrier, and G. Richet.
Service de Néphrologie, Hôpital Tenon, Paris, France. To test the
value of the search for urinary red cell casts, we studied the relation
between hematuria, proteinuria, casts, and renal histology. Red cell
casts were systematically and thoroughly searched for, on freshly
centrifuged urine, by phase-contrast microscopy, and also renal biop-
sies. Results. Among 69 cases, 58 were glomerulonephritis and 11
nonglomerular nephropathies; the latter had no hematuria or red cell
casts. The 58 cases of glomerulonephritis were classified according to:
(a) the presence (+) or absence (—) of hematuria (H) and urinary red
cell casts (C); (b) the presence or absence of cellular proliferation
(diffuse or focal and segmental) or renal histology; (c) the number of
cases with red cell casts in tubules on renal biopsy which is in
parenthesis.
Urinary
sediment Histology
Proliferative
Non-
proliferativeDiffuse
Focal and
segmental
H(+) C(+) 5(1) 0 0
H (+) C (—) 8 12(6) 4(1)
H(—) C(—) 2 0 27
In 7 cases, red cell casts were found on renal biopsies but not in the
urine (1 amyloidosis and 6 focal and segmental glomerulonephritis: 4
IgA and 2 angeitis). In 6 cases with hematuria without proteinuria,
glomerulonephritis was proven by renal biopsy (2 diffuse proliferative, 3
IgA, 1 nonproliferative). Conclusions. (1) We confirm that hematuria is
generally associated with proliferative glomerulonephritis (86%; 25/29).
In cases with proteinuria without hematuria, renal biopsy rarely demon-
strates proliferative glomerulonephritis. Hematuria without proteinuria
often reveals glomerulonephritis (6/29); (2) In 50% (6/12) of focal and
segmental glomerulonephritis, red cell casts were found on renal biopsy
but not in the urine; (3) Urinary red cell casts were only found in diffuse
proliferative glomerulonephritis; but their frequent absence in hema-
turic glomerulonephritis (80% of proliferative and 62% of diffuse
proliferative forms) considerably reduces the clinical value of this
search.
Preservation of renal function by phosphorus restriction: A nonspecific
effect? D. Laouari, C. Kleinknecht, M. Broyer, and F. Mounier.
INSERM U. 192, Hôpital des Enfants-Malades, Paris, France. The
deterioration of renal function (RF) in experimental renal insufficiency
may be slowed by a devoid phosphorus diet or by a poor protein diet.
The purpose of the study was to elucidate the respective role of these
two factors. Five groups of uremic rats were compared: three (A, B, C)
were fed ad lib diets differing exclusively in their phosphorus content
which was 0.03%, 0.2%, and 0.5%; two (D, E) received the 0.2% and
0.5% diets but were pairfed with A rats. A rats showed (1) a lower food
intakethanratsBandC(l3.5 18.5
a growth arrest while weight gain after 3 months was 50 12 and 88
20g in pairfed rats D and E (A vs. D orE, P < 0.05), and was 120 12
and 150 log in B and C rats fed ad lib, (3) a hypophosphoremia (0.75
0.05 mmoles/liter) with hypercalcemia (3.50 0.06 inmoles/liter),
which were less severe in B and D rats (calcium 3.0 0.1; phosphorus,
1.1 0.09 mmoles/liter), whereas C and E rats had normal serum
levels. Renal function was stable in all rats A, D, and E. Their mortality
was 20%, 20%, and 27% after 8 months, whereas mortality was 80% and
90% in B and C rats. Phosphorus intake was lower in B rats than in E
rats (1.18 0.04 vs. 2.53 0.22 mmoles/day during the first 3 months,
P < 0.001). In conclusion, the deterioration of RF was much more
closely related to food and protein intake than to phosphorus intake.
However, since deaths occurred earlier in C rats than in B rats, a slight
effect of phosphorus, possibly mediated by the greater weight gain,
cannot be excluded.
Strong association between HLA-DR4 and Berger's disease. P. Le
Pogamp, D. Chevet, P. Simon, M. P. Ramée, M. Gueguen, R.
Fauchet. Unite de Nephrologie, CHU Pontchaillou, Rennes, Service
de Néphrologie, C.H. La Bauchée, St Brieuc, Laboratoire d'Histocom-
patibilité, C.T.S., Rennes, France. Conflicting results have been pub-
lished concerning an association between Berger's disease and HLA-A
and -B antigens, especially Bw35 and B12. Forty-five consecutive
unrelated patients were therefore screened for HLA-A, -B, and -DR
antigens. All the patients had mesangial IgA deposits and no associated
systemic or liver disease. Controls for HLA-A and -B typing consisted
of 356 and for HLA-DR typing of 114 locally recruited healthy blood
donors. No significant HLA-A or HLA-B antigen excess was found,
whereas a slightly increased Bw35 antigen frequency was noted (28.9%
vs. 12.9%, P < 0.14). But there was a highly significant increase in the
frequency of HLA-DR4 (48.9% vs. 19.5%, P < 10 — 3; R = 3.96) with a
secondary association with Bw35 and A2-Bl2 antigen combination. The
preliminary results of clinical correlations will be presented.
Anti-GBM crescentic glomerulonephritis and angioimmunoblastic
lymphadenopathy. P. Le Pogamp, P. Y. Le Prise, M. P. Ramée, P.
Mahieu, and D. Chevet. Unite de Néphrologie, CHU Pontchaillou,
Rennes, Unite d'Hematologie, C.M.D., CHU Hôtel-Dieu, Rennes,
France, and Inst itut de Medecine, HOpital de Bavière, Liege, Belgium.
A 67-year-old patient developed simultaneously a glomerulopathy and a
lymphoproliferative disorder consisting of angioimmunoblastic lymph-
adenopathy. Hematologic data was typical: generalized lymphadenopa-
thy, hepatosplenomegaly, immunologic abnormalities, specific his-
tologic picture. Despite high-dose corticosteroid therapy, glomerulo-
pathy clinically worsened. A renal biopsy then performed disclosed a
crescentic glomerulonephritis (75% of crescents), with linear deposits
of IgG and C3 on immunofluorescence microscopy. The autoimmune
mechanism of the glomerulonephritis was assessed by high titers of
serum anti-GBM antibodies in RIA. Combination of cytotoxic drugs
and plasma exchanges induced a striking improvement of both syn-
dromes.
Comparative effects of propranolol and atenolol in the control of
secondary hyperparathyroidism of chronic renal failure. R. Makdassi, P.
Moriniere, B. Coevoet, J. Guéris, C. Calmettes, Flouvat, A. Fournier.
CHU Amiens, Hop. Lariboisiêre, St Antoine, et A. Pare, Paris,
France. Propranolol (P), a 131 + 132 blocker, has been proposed as the
treatment of choice of hypertension in uremic patients because it
suppresses PTH secretion when given iv. In general practice 131
betablockers are usually preferred because of various advantages.
However, we have previously shown that metoprolol (a 31 blocker) was
unable to suppress PTH secretion when acutely administered in uremic
patients. The aim of this randomized crossover study was to compare
the chronic effects of 2 months of therapy with either P or Atenolol (A),
another 131 blocker, when orally administered at equal antihypertensive
activity, in 24 nondialyzed uremic hypertensive patients, on their
plasma levels of PTH (C and N terminal assays), calcitonine, 25 OH D,
total calcium, phosphate, proteins, bicarbonate, urea, and creatinine.
Plasma levels of A and P, measured to check compliance, were found in
the usual therapeutic range. No significant difference was found, except
in plasma bicarbonate, which was higher with P (P < 0.05). It is
concluded that the long-term control of secondary hyperparathyroidism
is comparable with A and P. However these results could be interpreted
by an initially greater suppressive effect on PTH secretion with P, this
possibly leading to an increase of bicarbonate levels because of
increased tubular reabsorption and to a secondary fall of ionized
calcium with a subsequent rise of PTH secretion. This suppression of
PTH secretion, weaker with A than with P, is compatible with the in
vitro demonstration of 131 and 132 parathyroid receptors.
Effects of inclomethacin and possible role of prostaglandins on renal
calcium excretion. L. Monnier, L. Aguirre, C. Colette, and J. Mirouze.
Clinique des Maladies Métaboliques, Hopital St Eloi, Montpellier,
France. Prostaglandins (PG) act on the renal tubules, changing renal
cyclic AMP content, and water and sodium excretion. We evaluated the
possible role of PG on renal calcium excretion in humans through the
PG inhibitory effects of indomethacin. Methods. Renal calcium excre-
tion was evaluated by a technique which gives a specific index of
tubular calcium transport. After an i.v. bolus of 20 Ci of 47CaC12, the
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time courses of radioactivity both in urine (R[tI) and in the glomerular
ultrafiltrate (l[tJ) were measured. The latter was calculated from the
total plasma radioactivity after correction for the glomerular filtration
rate (GFR), and for the ionized plasma calcium. The time course, Ro(t),
of the urinary radioactivity after a 47Ca bolus theoretically injected
directly into the glomerular filtration system was obtained by applying
an inverse convolution procedure to R(t) and 1(t). Several parameters
were derived from Ro(t): (1) the total fractional urinary calcium
excretion as percent of total dose (TFEca, %TD) (2) the peak excretion
rate (Uca max, %TD), (3) the mean transit time (MTT, mm). Protocol.
The aforementioned parameters were determined in 7 healthy subjects
in basal conditions and again after 10 days of treatment with 100 mg of
indomethacin daily. The results are summarized below
Before After indomethacin P
TFEca, %TD 5.02 0.57 8.18 0.97 <0.02
Uca max, %TD/min 0.050 0.006 0.051 0.007 NS
MYF, mm 1.35 0.27 1.77 0.23 NS
Indomethacin produced an increase in calcium excretion. As indometh-
acm did not produce any significant change in GFR (125 7 mI/mm
before vs. 129 9 after) one can assume that PG plays a role in tubular
calcium reabsorption. However the mechanism remains to be elucidat-
ed: direct action or mediated through the cyclic AMP system.
Prospective study of gentamicin nephrotoxicity in the human kidney.
G. Paulus, G. Verpooten, R. Rutsaert, P. Tulkens, F. Rods, andM. E.
De Broe. Dept. Nephrology-Hypertension and Pathology, University of
Antwerp, Institute of Cellular and Molecular Pathology, Université
Catholique Louvain, MenselUke Anatomie, Vrije Universiteit Brussel,
Belgium. A prospective comparative study of nephrotoxicity of amino-
glycosides in the human kidney was made. The preliminary results of
the early nephrotoxicity of gentamicin (G) are reported. Patients with
renal neoplasia partly involving the kidney either received G, 1.5 mg/kg
t.i.d., during 4 days before surgical operation or served as controls. In
five patients treated with G, we made the following observations: G
accumulates in the renal cortex. Renal function remained unaltered.
Light microscopy showed no specific tubular lesions. Histochemistry of
the brush border (alkaline phosphatase, y-glutamyl-transferase, leu-
cine-aminopeptidase) was normal. Sphingomyelinase activity was nor-
mal. Electron microscopy (EM) showed the presence of dense osmio-
philic lamellar structures ("myeloid bodies"), generally occupying only
a limited area, within most of the lysosomes. The lysosomes were
identified by the deposit of acid phosphatase reaction product (lead
phosphate). G given at normal doses during 4 days induces early
lysosomal lesions similar to previously described lysosomal alterations
in patients with acute renal failure after prolonged G treatment. These
early lesions, however, were detected only by morphologic methods
(EM).
Preventive hemodialysis in pregnant woman with advanced renal
failure and severe hypertension. K. Rebaiz, F. Lesdain, B. Pierrot, and
C. Wolf Service de Medicine D, Orientation Nephrologique, et Service
de Gynecologie Obstetrique, Hôpital Manchester, Charleville-Me-
zieres, France. A 27-year-old woman, mother of a 6-year-old child, was
referred at the beginning of her second pregnancy for acute renal failure
(ARF) due to chronic pyelonephritis with bilateral vesicoureteric re-
flux. The creatinine clearance was IS mI/mm. The blood pressure
remained high (160/110 mm Hg) despite powerful antihypertensive
therapy by acebutolol, 800 mg/day, dihydralazine, 75 mg/day, and
clonidine 0.300 mg/day. The patient underwent PHD at the 24th week of
pregnancy to decrease the maternal and fetal risk. Hemodialysis (HD)
(Rhodial-RP 6 system) was performed for 3 hours thrice a week with an
arteriovenous fistula. Early during dialysis, she developed uterine
contractions which were suppressed by salbutamol (3 mg/day). The
obstetrical followup was done by serial ultrasound scanning, monitoring
of fetal beats and amniocentesis. An hydramnios was present. The
delivery by vaginal route occurred at the 34th week of gestation. The
l700-g male infant showed no congenital abnormality and had an Apgar
score of 9. HD was discontinued 2 months after delivery but it had to be
resumed 12 months later. In this case, the benefits of preventive HD
were the control of hypertension (115/75 mm Hg) with a minimal
treatment (clonidine, 0.300 mg/day), the improvement of nutrition with
a free diet and the suppression of acidosis. This case and the review of
the literature demonstrate that the indications of preventive HD in
pregnancy should be based on the diagnosis of the nephropathy, the
severity of renal failure, and the poor control of hypertension by
antihypertensive drugs.
Evidence for the presence of antidiuretic and antinatriuretic factors in
human cirrhotic ascites. M. Robin, P. Cambier, J. P. Godon, and A.
Nizet. Inst it ut de Medicine, Département de Clinique et de Semeiologie
médicales, Université de Liege, Liege, Belgique. The factors involved
in the pathogenesis of cirrhotic ascites (CA) are numerous, but their
relative influence is poorly known. The disappearance of a natriuretic
hormone was suggested as a possible cause. Our study was performed
to investigate in alcoholic CA (N = 7) other factors suitable to explain
the salt and water retention. We used the administration of CA samples
in two bioassays: (1) totally isolated blood-perfused paired dog kidneys(N = 9) supplemented by ADH and DOCA, (2) cell-free perfused rat
kidneys (N = 17). We used as control an artificial medium of the same
ionic and oncotic concentration. The AC administration induced in the
dog kidneys a strongly significant decrease (2 P <0.001) of diuresis and
absolute as well as fractional sodium excretion as compared to controls.
In the rat system, we observed the same significant decrease (2 P <
0.001) of water and sodium excretion after AC injection. In both
bioassays, no significant variation of RPF and GFR was observed.
Conclusions. Our experiments were performed in conditions precluding
the involvement of an aldosterone or vasopressin increase on a natri-
uretic hormone decrease. Thus, we have demonstrated in such patients
the presence of at least one factor inducing water and sodium tubular
reabsorption in two species. These factor(s) could play a role in the
hydroionic retention observed in human cirrhotic ascites.
IgA nephritis in infectious mononucleosis. P. Simon, 0. Nouel, K. S.
Ang, Y. Deugnier, and M. P. Ramée. Service de Néphrologie et Service
de Gastro-Enterologie, Centre Hospitalier La Beauchée, Saint-B rieuc,
et Service d'Anatomie Pat hologique, C.H. U. de Pontchaillou, Rennes,
France. A 17-year-old girl developed macroscopic hematuria during
infectious mononucleosis (acute pharyngitis, cervical lymphadeno-
pathy, splenomegaly, urticarial rash, anicteric hepatitis). The Paul
Bunnell test was negative, and 1gM antibodies to EB-viral capside
antigens (IgM-VCA) were positive to 1/640. Liver biopsy studied by
light and electron microscopy showed lesions compatible with infec-
tious mononucleosis. Renal biopsy showed, by light microscopy, mild
focal and segmental glomerulonephritis; by electron microscopy, small
subendothelial dense deposits; and by direct immunofluorescence stain-
ing, granular deposits of IgA, 1gM, and fibrin along the peripheral loops.
More effort should be directed to studying the role of Epstein Barr virus
in young adults with IgA nephritis.
Porphyria cutanea tarda-like dermatosis in hemodialyzed patients: Ten
cases. F. Schillinger, J. M. Chalopin, C. Corbin, R. Montagnac, B.
Perrier, S. Corbin, E. Jusirabo, G. Rifle. Service de Nephrologie, CHG
Troyes, Centre Medico-Chirurgical de Chaumont-le Bois, Service de
Nephrologie et Reanimation Melabolique, CHU Dijon, France. Among
250 patients on maintenance hemodialysis in three centers, 10 patients
(2 females, 8 males), with an age range of2l to 63 years (mean, 44 years)
developed porphyria cutanea tarda-like syndrome, 2 to 72 months after
initiating hemodialysis treatment (mean, 19 months). Bullous lesions
were located on sunlight-exposed areas. They looked like those caused
by porphyria cutanea tarda (PCT) in every aspect. Their course was
mostly characterized by attacks during the summer. Five patients had
only one attack, two had 2, and one had 4 during four following
summers. However, in two patients, the skin lesions were permanent,
increasing in the summertime. Nine out of ten patients also showed
increased cutaneous fragility in response to trauma, and three had milia.
One patient was successfully transplanted during 16 months: the skin
lesions decreased but did not disappear. In every case, coproporphyrin
or uroporphyrin levels in red cells, and urine and stool specimens were
normal. Under light-microscopic examination (six patients), the skin
lesions were indistinguishable from PCT. Immunofluorescence studies
were carried out in four cases: IgG granular deposits were noticed at the
dermoepidermaljunction in one case. The pathogenesis of this dermato-
sis, of which about 50 cases have been reported, remains unknown. A
linkage had been suggested between this syndrome and HLA-B-l2:
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HLA typing revealed the presence of this antigen in two out of six
patients studied. In our series, we have found no obvious relation with
initial disease, the dialysers used, the quality of water, or the adminis-
tration of drugs. Seven of these ten patients were being treated with
furosemide during their attacks. The plasma aluminum concentration of
these patients was not different from the other hemodialyzed patients of
the same centers. A possible tissue accumulation of this metal, particu-
larly regarding the liver, cannot be eliminated; no liver biopsy was
made. On the contrary, nine of ten patients have minor hepatic
abnormalities: presence of the HBs Ag in seven cases and in four cases
excessive alcohol consumption. Moreover, transient increases in the
serum transaminase levels occurred in five cases at the time of attacks.
From a therapeutic point of view, two patients improved after oral
administration of carotenoids, 2.5 mg/kg/day.
Home peritoneal dialysis, long-term treatment of end-stage renal
disease patients with insulin-dependent diabetes mellitus: Five years'
experience. A. Slingeneyer, J. L. Selam, C. Mion. Dept. Nephrology,
University Hospital, Montpellier, France. From September 1975 to
September 1980, 16 patients with insulin-dependent diabetes mellitus
(IDD) (mean age, 34.2 5.8 years) entered our home peritoneal dialysis(HPD) program. At start of treatment, residual creatinine clearance
(Ccr) was (mean SD): 6.7 3.2 mI/mm. All patients had intermittent
PD (IPD) three times a week with 120 to 150 liters of dialysate per week,
for a cumulative treatment duration of 35.5 patient years; 7 patients
were transferred to continuous ambulatory peritoneal dialysis (CAPD)
(cumulative treatment duration, 6.4 patient years). Insulin was given
s.c. in 14 patients and i.p. in 2 CAPD patients. During the first week of
treatment, a 10.8% mean body weight loss, due to fluid removal, was
observed: it was associated with a significant decrease of Ccr, which
was I 0.8 mI/mn at the end of the first year. In 50% of the patients,
long-term blood pressure control was difficult to maintain due to
symptomatic orthostatic hypotension. In 8 patients, diabetes control
was poor according to Schlichtkrull M-value; HbA1 was 11.2 2,2%
(normal, 5 to 8.5%). Biochemistries were (in g/liter): urea, 1.4 0.4;
triglycerides, 2.6 0.7; total proteins, 66 6.1; albumin, 36.5 7.6;
creatinine, 13.0 3.4 mgldl; haematocrit, 37.3 9.6%. There were few
infections: 2 peritonitis episodes (PE) in IPD (1 PE every 17.2 patient
treatment years) and 3 PE in CAPD (I PE every 20.8 patient treatment
months). Five of 13 patients with neuropathy at start of treatment
improved and 2 deteriorated. Vision improved in 5 patients and
decreased in 1; amputation was not required in any patient. There was
only one death due to peritonitis associated to acute appendicitis after
34 months of IPD. The actuarial survival rate was 89% at 3 years. These
results suggest that PD offers a good therapeutic alternative to the
insulin-dependent diabetic with ESRD: both a low incidence of peritoni-
tis and no acceleration in degenerative vascular disease contributes to a
high actuarial survival rate.
Anemia and aluminum intoxication: An experimental study in rats. M.
Touam, F. Martinez, B. Lacour, and T. Drdeke. INSERM U.90 and
Nephrology Department, Necker Hospital, Paris, France. In aluminum
(Al) intoxicated hemodialysis patients, a microcytic anemia has been
recently observed. The part that Al could play in the pathogenesis of
their anemia remains, however, hypothetical. We have allocated two
groups of 10 normal rats, respectively, to daily peritoneal injections of
either a solution of aluminum sulfate (710 i.g of elemental Al) or the
vehicle solution. Blood samples were taken 2 and 3 months after
starting this treatment. After 2 months of Al intoxication versus vehicle
injection, a significant decrease was observed in hematocrit (13 0.8
vs. 29 0.8%), RBC count (2.3 0.15 vs. 5.1 0.14 x 106/mm3), and
hemoglobin (12.6 0.3 vs. 15.6 0.2 g/dl). After 3 months of
treatment, these differences between both groups were even more
pronounced. Moreover, the anemia of Al-intoxicated rats then became
microcytic (MCV, 52.7 0.3 vs. 56.3 0.3 3), strikingly hyperchro-
mic (MCHC, 134 7 vs. 52 2 ig%), and hyporegenerative. Their
serum iron concentration was significantly lower than that of controls
(18 1.1 vs. 29 1.3 i.moles/Iiter). Conclusion. Heavy aluminum
intoxication in normal rats induces a microcytic and hyporegenerative,
profound anemia which cannot be explained by a concomitant moderate
iron deficiency alone. This anemia is unexpectedly hyperchromic. The
latter was not observed in our hemodialysis patients with severe
aluminum intoxication whose anemia was microcytic and normochro-
mic.
Wegener granulomatosis: A survey of three cases. 0. Toupance, J. P.
Melin, S. Lavaud, C. Beranger, P. Birembaut, J. P. Brunois, and J.
Chanard. Service de Néphrologie et Laboratoire Pol Bouin, C.H. U.
Reims, France. Three male patients, 41, 50, and 56 years old, having
Wegener granulomatosis were treated for 7 to 19 months. The initial
picture of the disease included the following localizations: 3/3 lungs, 2/3
upper respiratory tract, 2/3 necrotic purpura, 2/3 kidneys with subacute
glomerulonephritis. Therapy was started with prednisone (1.5 mg/kg/
day) and azathioprine (2.5 mg/kg/day) in one patient and with predni-
sone, cyclophosphamide (2.5 mg/kg/day) and plasma exchange in the
two others. Remission was obtained in the first months of therapy.
Renal function returned toward normal in one and renal insufficiency
was maintained in plateau in the other. After 6 months on azathioprine,
hematologic toxicity occurred, the dose was decreased, resulting in a
fatal relapse. After 6 months on cyclophosphamide, the patient without
renal involvement stopped the drug while maintaining prednisone.
Subacute glomerulonephritis requiring hemodialysis occurred 2 months
later, and improvement of renal function (creatinine clearance increas-
ing from 5 to 30 mI/mm) was achieved in reintroducing cyclophospha-
mide and plasma exchanges. The third patient still on cyclophospha-
mide (1.5 mg/kg/day) is doing well after 19 months. From this study it
appears that (1) cyclophosphamide (1.5 to 2 mg/kg/day) in association
with prednisone, as proposed by Fauci, is the most suitable therapy of
Wegener granulomatosis and (2) plasma exchange seems to have a
beneficial effect at the start of therapy.
Role of renal vasoconstriction in the pathogenesis of mercuric-chloride-
induced renal failure. R. Vanholder, J. Verbanck, S. Ringoir, and N.
Lameire. Renal Division, Department of Internal Medicine, University
Hospital, De Pintelaan, Belgium. Acute toxic renal failure was induced
in dogs by the i.v. bolus injection of HgCl2 at a dose of 3 mg/kg. Within
a 3-hour period, an almost parallel decrease in glomerular filtration rate
(GFR) and renal plasma flow (RPF) by more than 40% and an increase
in urinary volume and urinary sodium excretion were observed. Renal
vasoconstriction was then adequately prevented in this model by the
administration of the plasma volume expander Haemaccel® alone or in
combination with the alpha-blocker phentolamine. Despite stabilization
of RPF, GFR in the Haemaccel0-phentolamine group fell at the same
rate as in the unpretreated HgCI2 dogs. In the Haemaccel® group, RPF
remained constant, and GFR, 3 hours after HgCI2 administration,
decreased by only 18% compared to the control GFR value. The less
pronounced fall in GFR appeared essentially due to a rise in GFR by
more than 10% after Haemaccel® before the HgCI2 was administered.
Comparison of the GFR with the experimental pre-HgCI2 volume-
expanded GFR revealed a similar procentual fall as in the unpretreated
animals. Finally, in both volume-expanded groups, urine and electro-
lyte losses were more pronounced than after HgCl2 alone. It is
concluded that renal vasoconstrmction apparently occurs concomitantly
with a fall in GFR in the early stage of HgCI2-induced ARF. However,
these changes in renal hemodynamics do not play an important pathoge-
netic role in the generation of the ARF in this model.
